# Photronics Inc: Form 10-Q for the period ended Apr 30, 2017

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2017-06-08
- Accepted by EDGAR: Jun 7, 2017, 18:57 ET
- Period: 2017-04-30
- Accession: 0001140361-17-024405
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036117024405/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036117024405/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-04-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 6 months, 2016-10-31 to 2017-04-30 | $218.1m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2017-01-30 to 2017-04-30 | $88.1m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2016-10-31 to 2017-04-30 | $175.0m | us-gaap:CostOfGoodsSold |
| Research and development | 3 months, 2017-01-30 to 2017-04-30 | $3.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2016-10-31 to 2017-04-30 | $7.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-30 to 2017-04-30 | $10.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2016-10-31 to 2017-04-30 | $21.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-30 to 2017-04-30 | $5.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2016-10-31 to 2017-04-30 | $14.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-01-30 to 2017-04-30 | $431.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2016-10-31 to 2017-04-30 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-30 to 2017-04-30 | $1.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2016-10-31 to 2017-04-30 | $3.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-30 to 2017-04-30 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2016-10-31 to 2017-04-30 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-01-30 to 2017-04-30 | $0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2016-10-31 to 2017-04-30 | $0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-01-30 to 2017-04-30 | 69,385,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2016-10-31 to 2017-04-30 | 69,277,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months, 2016-10-31 to 2017-04-30 | $14.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2017-04-30 | $345.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-04-30 | $472.5m | us-gaap:AssetsCurrent |
| Total assets | at 2017-04-30 | $1.02bn | us-gaap:Assets |
| Current liabilities | at 2017-04-30 | $92.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-04-30 | $170.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-04-30 | $729.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 22,514 characters.

### Overview

Management’s discussion and analysis (“MD&A”) of the Company’s financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations and may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company’s Annual Report on Form 10-K for the fiscal 2016 year), that may cause actual results to materially differ from these expectations.

The Company sells substantially all of its photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher performance electronic products such as photonics, micro-electronic mechanical systems and certain nanotechnology applications. Thus, the Company’s selling cycle is tightly interwoven with the development and release of new semiconductor designs and flat panel applications, particularly as it relates to the semiconductor industry’s migration to more advanced design methodologies and fabrication processes. The Company believes that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks even if demand for semiconductors and FPDs increases. Advances in semiconductor, FPD and photomask design and semiconductor and FPD production methods could also reduce the demand for photomasks. Historically, the semiconductor industry has been volatile, with sharp periodic downturns and slowdowns. These downturns have been characterized by, among other things, diminished product demand, excess production capacity and accelerated erosion of selling prices.

The global semiconductor industry, including mobile displays, is driven by end markets which have been closely tied to consumer driven applications of high performance semiconductor devices including, but not limited to, mobile communications and computing solutions. The Company is typically required to fulfill its customer orders within a short period of time, sometimes within 24 hours. This results in the Company having a minimal level of backlog orders, typically one to two weeks for IC photomasks and two to three weeks for FPD photomasks. The Company cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes or the timing of up and down cycles with precise accuracy, but believes that such transitions and cycles will continue into the future, beneficially and adversely affecting its business, financial condition and operating results as they occur. The Company believes its ability to remain successful in these environments is dependent upon achieving its goals of being a service and technology leader and efficient solutions supplier, which it believes should enable it to continually reinvest in its global infrastructure.

In May 2017 the Company announced that it had entered into an agreement to form a joint venture that would be based in Xiamen, China. Please refer to Note 15 of the condensed consolidated financial statements for additional information.

### Material Changes in Results of Operations

### Three and Six Months ended April 30, 2017 and May 1, 2016

The following table represents selected operating information expressed as a percentage of net sales.

|  | Three Months Ended April 30, 2017 | May 1, 2016 | Six Months Ended April 30, 2017 | May 1, 2016 |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | (81.4) | (74.5) | (80.2) | (73.6) |
| Gross margin | 18.6 | 25.5 | 19.8 | 26.4 |
| Selling, general and administrative expenses | (10.1) | (9.0) | (10.0) | (9.2) |
| Research and development expenses | (3.4) | (4.4) | (3.3) | (4.4) |
| Operating income | 5.1 | 12.1 | 6.5 | 12.8 |
| Other income (expense), net | (3.3) | (2.5) | (2.6) | (0.8) |
| Gain on sale of investment | - | - | - | 3.4 |
| Income before income tax benefit (provision) | 1.8 | 9.6 | 3.9 | 15.4 |
| Income tax benefit (provision) | (0.4) | 1.9 | (1.2) | (0.5) |
| Net income | 1.4 | 11.5 | 2.7 | 14.9 |
| Net (income) loss attributable to noncontrolling interests | 0.3 | (1.9) | (1.0) | (1.9) |
| Net income attributable to Photronics, Inc. shareholders | 1.7% | 9.6% | 1.7% | 13.0% |

Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended April 30, 2017 (Q2-17) and May 1, 2016 (Q2-16) and for the six months ended April 30, 2017 (YTD-17) and May 1, 2016 (YTD-16), in millions of dollars.

### Net Sales

|  | Three Months Ended Q2-17 | Q2-16 | Percent Change | Six Months Ended YTD-17 | YTD-16 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| IC | $82.6 | $90.9 | (9.1)% | $169.0 | $190.6 | (11.3)% |
| FPD | 25.7 | 32.0 | (19.9)% | 49.1 | 62.3 | (21.1)% |
| Total net sales | $108.3 | $122.9 | (11.9)% | $218.1 | $252.9 | (13.7)% |

Net sales for Q2-17 decreased 11.9% to $108.3 million as compared with $122.9 million for Q2-16. The decrease was primarily the result of lower demand for high-end products for both IC and FPD photomasks. Revenues attributable to high-end products decreased by $19.4 million to $38.7 million in Q2-17, as compared with $58.1 million in Q2-16. Net sales for YTD-17 decreased to $218.1 million as compared with $252.9 million for YTD-16. This decrease was also the result of weakened demand for both high-end IC and FPD photomasks which, combined, decreased by $41.8 million to $81.4 million in YTD-17 as compared with $123.2 million in YTD-16. High-end photomask applications include mask sets for 45 nanometer and below for IC products, and G8 and above and active matrix organic light-emitting diode (AMOLED) display screen technologies for FPD products.

We saw improving demand across the business during the quarter, and believe these positive trends will continue as we move into the second half of the year. Looking ahead, for IC photomasks, we believe growth in high-end memory products will be driven by increased foundry demand. We expect a shift in our 28 nanometer logic business, as our largest IC customer has obtained approval from the Taiwanese government to commence 28 nanometer node production in China. This customer will be the first volume producer of the High-K metal gate version of 28 nanometer IC in China. As a result, we should see improved high-end logic photomask sales. However, it is difficult to predict with certainty when we will benefit from these developments.

FPD sales increased during Q2-17 and both of our FPD facilities were near full capacity at the end of the quarter. We anticipate that we will continue to operate at or near full capacity over the next several quarters, even as we install and qualify two new writing tools at our FPD facilities. We believe the continuing transition to AMOLED displays for smartphones will be a major driver of this activity.

The Company’s quarterly revenues can be affected by the seasonal purchasing of its customers. Demand for the Company’s products is typically negatively impacted during the first six months of its fiscal year by the North American, European and Asian holiday periods, as some customers reduce their effective workdays and orders during this period.

The following table presents changes in net sales from Q2-16 to Q2-17 and YTD-16 to YTD-17 by geographic area:

|  | Net Sales in Q2-17 | Q2-16 to Q2-17 Percent Change | Increase (Decrease) | Net Sales in YTD-17 | YTD-16 to YTD-17 Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $42.3 | (9.5)% | $(4.4) | $88.7 | (7.1)% | $(6.7) |
| Korea | 30.9 | (13.1)% | (4.6) | 61.2 | (14.5)% | (10.4) |
| United States | 25.9 | (17.8)% | (5.6) | 49.6 | (27.5)% | (18.9) |
| Europe | 8.7 | 1.5% | 0.1 | 17.4 | 5.5% | 0.9 |
| Other | 0.5 | (13.2)% | (0.1) | 1.2 | 29.3% | 0.3 |
|  | $108.3 | (11.9)% | $(14.6) | $218.1 | (13.7)% | $(34.8) |

### Gross Margin

|  | Three Months Ended Q2-17 | Q2-16 | Percent Change | Six Months Ended YTD-17 | YTD-16 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross margin | $20.2 | $31.3 | (35.6)% | $43.2% | $66.7 | (35.3)% |
| Percentage of net sales | 18.6% | 25.5% |  | 19.8% | 26.4% |  |

Gross margin percentage decreased to 18.6% in Q2-17 from 25.5% in Q2-16, and to 19.8% in YTD-17 from 26.4% YTD-16. Both of the decreases resulted from the declines in overall sales and sales of high-end products, as a percent of total sales, in the current year periods from their comparative prior year periods. The Company operates in a high fixed cost environment and, to the extent that the Company’s revenues and utilization increase or decrease, gross margin will generally be positively or negatively impacted.

### Selling, General and Administrative Expenses

|  | Three Months Ended Q2-17 | Q2-16 | Percent Change | Six Months Ended YTD-17 | YTD-16 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | $10.9 | $11.0 | (1.2)% | $21.8 | $23.2 | (6.3)% |
| Percentage of net sales | 10.1% | 9.0% |  | 10.0% | 9.2% |  |

Selling, general and administrative expenses did not change significantly in Q2-17 as compared to Q2-16. Year to date, selling, general and administrative expenses decreased 6.3% compared to the prior period, primarily due to lower compensation expenses and professional and other service charges.

### Research and Development

|  | Three Months Ended Q2-17 | Q2-16 | Percent Change | Six Months Ended YTD-17 | YTD-16 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $3.7 | $5.4 | (31.6)% | $7.2 | $11.1 | (35.3)% |
| Percentage of net sales | 3.4% | 4.4% |  | 3.3% | 4.4% |  |

Research and development expenses consist primarily of global development efforts related to high-end process technologies for advanced sub-wavelength reticle solutions for IC technologies. Research and development expenses decreased by $1.7 million to $3.7 million in Q2-17, as compared with $5.4 million in Q2-16. YTD-17 research and development expenses decreased by $3.9 million to $7.2 million, as compared with $11.1 million in YTD-16. These decreases were primarily the result of fewer activities at advanced nanometer technology nodes for IC photomasks, in both the U.S. and Asia.

### Other Income (Expense), net

|  | Three Months Ended Q2-17 | Q2-16 | Six Months Ended YTD-17 | YTD-16 |
| --- | ---: | ---: | ---: | ---: |
| Interest and other income (expense), net | $(3.1) | $(2.0) | $(4.6) | $- |
| Interest expense | (0.5) | (1.0) | (1.1) | (2.1) |
| Gain on sale of investment | - | - | - | 8.8 |
| Other income (expense), net | $(3.6) | $(3.0) | $(5.7) | $6.7 |

Interest and other income (expense), net decreased in Q2-17, as compared with Q2-16, by $1.1 million and decreased $4.6 million in YTD-17, as compared with YTD-16, as a result of increased unfavorable foreign currency transaction results.

Interest expense decreased by $0.5 million in Q2-17, as compared with Q2-16, and by $1.0 million in YTD-17, as compared with YTD-16, primarily as a result of the impact of the 3.25% convertible debt that matured on April 1, 2016.

In January 2016 the Company sold a minority interest investment in a foreign entity and recognized a gain of $8.8 million.

### Income Tax Benefit (Provision)

|  | Three Months Ended Q2-17 | Q2-16 | Six Months Ended YTD-17 | YTD-16 |
| --- | ---: | ---: | ---: | ---: |
| Income tax benefit (provision) | $(0.4) | $2.3 | $(2.5) | $(1.4) |
| Effective income tax rate | 22.5% | (19.7)% | 29.3% | 3.5% |

The Company’s effective income tax rate is sensitive to the jurisdictional mix of earnings, due in part to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate increased in Q2-17 and YTD-17, as compared with Q2-16 and YTD-16, primarily as a result of the following factors: the recognition in Q2-16 and FY-16 of $2.5 million of previously unrecognized deferred tax assets, which resulted from the improved performance of the Company’s FPD operations; the reversal of previously recognized tax expense of $2.4 million that was eliminated by a distribution of the FY-15 earnings of a foreign subsidiary to its foreign parent; a higher percentage of income before income taxes, including the $8.8 million gain on the sale of investment in Q1-16, generated in jurisdictions where the company previously incurred losses that, due to valuation allowances, did not result in the Company recognizing expense. These positive factors were offset in part by the accrual of $0.7 million of withholding taxes related to a foreign subsidiary’s share redemption in a foreign jurisdiction. As of each reporting date, the Company considers new evidence, both positive and negative, that could impact management’s view with regards to the future realizations of deferred tax assets.

### Net (Income) Loss Attributable to Noncontrolling Interests

Net (income) loss attributable to noncontrolling interests decreased $2.6 million to $0.3 million in Q2-17, as compared with $(2.3) million in Q2-16, and decreased by $2.5 million to $(2.3) million in YTD-17, as compared with $(4.8) million in YTD-16, as a result of decreased net income of the Company’s IC manufacturing facility in Taiwan.

### Liquidity and Capital Resources

The Company’s working capital increased to $380.5 million at April 30, 2017, as compared with $360.3 million at October 30, 2016. Cash and cash equivalents increased to $345.7 million at April 30, 2017, as compared with $314.1 million at October 30, 2016. Both of these increases were primarily due to cash generated from operating activities. Net cash provided by operating activities was $46.9 million for the six month period ended April 30, 2017, as compared with $65.1 million for the six month period ended May 1, 2016, with the decrease being primarily due to decreased net income. Net cash used in investing activities for the six month period ended April 30, 2017, was $19.8 million, which was comprised primarily of capital expenditure payments and, to a lesser extent, a payment to acquire a business. Net cash used in financing activities of $0.4 million for the six month period ended April 30, 2017, was comprised of repayments of long-term borrowings of $2.7 million, partially offset by proceeds of $2.3 million received from exercises of employee stock options. The Company may use its available cash for operations, capital expenditures, debt repayments, strategic opportunities, stock repurchases or other corporate uses, any of which may be material.

As of April 30, 2017 and October 30, 2016, the Company’s total cash and cash equivalents include $184.3 million and $141.4 million, respectively, held by its foreign subsidiaries. The majority of earnings of the Company’s foreign subsidiaries are considered to be indefinitely reinvested. The repatriation of these funds to the U.S. may subject these funds to U.S. federal income taxes and local country withholding tax in certain jurisdictions. The Company’s foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.

In April 2017 PDMC, the Company’s majority owned IC manufacturing subsidiary in Taiwan, declared a dividend of approximately $16.8 million, approximately $8.4 million of which is expected to be paid to the third party that owns a noncontrolling interest in PDMC in the third fiscal quarter of 2017.

In April 2016 PDMC, the Company’s majority owned IC manufacturing subsidiary in Taiwan, declared a dividend of approximately $23.8 million, approximately $11.9 million of which was paid to the third party that owns a noncontrolling interest in PDMC in the third fiscal quarter of 2016.

In April 2016 $57.5 million of the Company’s senior convertible notes matured. The Company repaid $50.1 million to noteholders and issued approximately 0.7 million shares to noteholders that elected to convert their notes to common stock. The notes were exchanged at the rate of approximately 96 shares per $1,000 note principle, equivalent to a conversion rate of $10.37 per share.

The Company’s credit facility, which expires in December 2018, has a $50 million limit with an expansion capacity to $75 million, and is secured by substantially all of the Company’s assets located in the United States and common stock the Company owns in certain of its foreign subsidiaries. The credit facility is subject to a minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance financial covenants, all of which the Company was in compliance with at April 30, 2017. The Company had no outstanding borrowings against the credit facility at April 30, 2017, and $50 million was available for borrowing. The interest rate on the credit facility (2.24% at April 30, 2017) is based on the Company’s total leverage ratio at LIBOR plus a spread, as defined in the credit facility. In May 2017 the credit facility was amended to add certain covenants for our new joint venture in China and other potential investments. See Note 15 of the condensed consolidated financial statements for further discussion of our new joint venture in China.

As of April 30, 2017, the Company had capital equipment commitments outstanding of approximately $62 million. The Company believes that its currently available resources, together with its capacity for growth, and its access to equity and other financing sources, will be sufficient to satisfy its currently planned capital expenditures, as well as its anticipated working capital requirements for the next twelve months. However, the Company cannot assure that additional sources of financing would be available to the Company on commercially favorable terms should the Company’s capital requirements exceed cash available from operations, existing cash, and cash available under its credit facility.

The Company’s liquidity is highly dependent on its sales volume, cash conversion cycle, and the timing of its capital expenditures (which can vary significantly from period to period), as it operates in a high fixed cost environment. Depending on conditions in the semiconductor and FPD markets, the Company’s cash flows from operations and current holdings of cash may not be adequate to meet its current and long-term needs for capital expenditures, operations and debt repayments. However, the Company believes its cash on hand, cash generated from its operations and cash committed under its credit facility will allow it to fund its operations through at least the next twelve months. Historically, in certain years, the Company has used external financing to fund these needs. Due to conditions in the credit markets, some financing instruments used by the Company in the past may not be currently available to it. The Company continues to evaluate further cost reduction initiatives. However, the Company cannot assure that additional sources of financing would be available to it on commercially favorable terms, should its cash requirements exceed cash available from operations, existing cash, and cash available under its credit facility.

### Off-Balance Sheet Arrangements

In April 2014, the Company acquired a 50.01% controlling interest of PDMC, its IC manufacturing facility located in Taiwan. Under the PDMC joint venture operating agreement the shareholders of PDMC may be requested to make additional contributions to PDMC. In the event that PDMC requests additional capital from its shareholders, the Company may, in order to maintain a 50.01% ownership interest, be required to make such contributions to PDMC. The PDMC operating agreement limits the amount of contributions that may be requested during both PDMC’s first four years and during any individual year within those first four years. As of April 30, 2017, the Company had not been requested to make any additional capital contributions to PDMC.

The Company leases certain office facilities and equipment under operating leases that may require it to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.

### Business Outlook

A majority of the Company’s revenue growth is expected to continue to come from the Asian region, predominantly in China. In response to this expectation, the Company has agreed to enter into a joint venture that will complete the construction of an IC research and development and manufacturing facility in Xiamen, China, in 2017. Production is anticipated to begin at this facility in late 2018.

The Company continues to assess its global manufacturing strategy and monitor its sales volume and related cash flows from operations. This ongoing assessment could result in future facility closures, asset redeployments, additional impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.

The Company’s future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties. While various risks and uncertainties were discussed in Part1, Item 1A in the Company’s Annual Report on Form 10-K for the year ended October 30, 2016, a number of other unforeseen factors could cause actual results to differ materially from the Company’s expectations.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 16 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 2,631 characters.

### Foreign Currency Exchange Rate Risk

The Company conducts business in several major international currencies through its worldwide operations and its financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect the Company’s sales, operating margins, assets, liabilities, and equity. The functional currencies of the Company’s Asian subsidiaries are the South Korean won, the New Taiwan dollar, and the Singapore dollar. The functional currencies of the Company’s European subsidiaries are the British pound and the euro. In addition, the Company has transactions and balances in Japanese yen and, as a result of its investment in a facility in Xiamen, China, the construction of which is currently underway, the Company will have significant transactions in the Chinese renminbi.

The Company attempts to minimize its risk of foreign currency transaction losses by producing its products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing its working capital. There can be no assurance that this approach will continue to be successful, especially in the event of a significant adverse movement in the value of any foreign currency against the U.S. dollar, the New Taiwan dollar or the South Korean won. However, in some instances, the Company sells products in a currency other than the functional currency of the country where it was produced or purchases products in a currency that differs from the functional currency of the manufacturing facility.

The Company’s primary net foreign currency exposures as of April 30, 2017, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Singapore dollar, the British pound and the euro. As of April 30, 2017, a 10% adverse movement in the value of these currencies against the functional currencies of the foreign subsidiaries would have resulted in a net unrealized pre-tax loss of $13.9 million. The Company does not believe that a 10% change in the exchange rates of other non-US dollar currencies would have a material effect on its consolidated financial position, results of operations, or cash flows in the three or six month periods ended April 30, 2017.

### Interest Rate Risk

At April 30, 2017, the Company did not have any variable rate borrowings. A 10% change in interest rates would not have had a material effect on the Company’s consolidated financial position, results of operations, or cash flows in the three or six month periods ended April 30, 2017.

## Controls and procedures

As filed, 2,042 characters.

### Evaluation of Disclosure Controls and Procedures

The Company has established and currently maintains disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), designed to provide reasonable assurance that information required to be disclosed in its reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company’s management, under the supervision and with the participation of the Company’s chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation the Company’s chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

### Changes in Internal Control over Financial Reporting

There was no change in the Company’s internal control over financial reporting during the Company’s second quarter of fiscal year 2017 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 175 characters.

There have been no material changes to risks relating to the Company’s business as disclosed in Part 1, Item 1A of the Company’s Form 10-K for the year ended October 30, 2016.

Filed Jun 8, 2017.
Source: SEC EDGAR, the filing index for accession 0001140361-17-024405. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
